Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Factors associated with choice of antipsychotic treatment in elderly veterans: potential confounders for observational studies
Author: Pratt, N.
Roughead, E.
Salter, A.
Ryan, P.
Citation: Australian and New Zealand Journal of Public Health, 2010; 34(6):589-593
Publisher: Public Health Assoc Australia Inc
Issue Date: 2010
ISSN: 1326-0200
Statement of
Nicole Pratt, Elizabeth Roughead, Amy Salter and Philip Ryan
Abstract: Background: Antipsychotics are commonly used in the elderly despite limited efficacy and safety data from randomised controlled trials. Observational comparative safety studies of antipsychotics vary, which may be due toconfounding. Objective: To compare the characteristics of typical and atypical antipsychotic initiators. Methods: Using the Australian Government Department of Veterans’ Affairsclaims dataset, we compared patient and prescribing physician characteristics and health care utilisation between atypical and typical antipsychotic initiators. Significant independent predictors of use were calculated using a multivariate log-binomial model. Results: Compared to patients initiated on typical antipsychotics (N=10,966), patients initiated on atypical antipsychotics (N=9,239) were less likely to be male (Relative Risk (RR)=0.91, 95% CI 0.89-0.94) and have prior dispensing of morphine (RR=0.53, 95% CI 0.49-0.57) and oral corticosteroids (RR=0.86, 95% CI 0.81-0.91) and to have been hospitalised for myocardial infarction or pneumonia. Patients initiated on atypical antipsychotics were more likely to be in aged care (RR=1.08, 95% CI 1.05-1.12), to be prescribed the medicine by their usual doctor (RR=1.12, 95% CI 1.09-1.16) and have prior dispensing of anticholinesterases (RR=1.19, 95% CI 1.15- 1.23), antidepressants (RR=1.18 95% CI 1.15-1.22) and anti-parkinson medications (RR=1.30, 95% CI 1.25-1.36). Conclusions: Differences between typical and atypical antipsychotic initiators indicate the potential for confounding in observational studies. Future pharmacoepidemiogical research in Australia, investigating the adverse events of antipsychotics, should consider the variables identified in this study to control for confounding.
Keywords: antipsychotic agents
confounding factors
Rights: © 2010 The Authors. ANZJPH © 2010 Public Health Association of Australia
DOI: 10.1111/j.1753-6405.2010.00613.x
Published version:
Appears in Collections:Aurora harvest
Public Health publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.